Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol
Crystal structure of brivanib (( R )-1-(4-(4-fluoro-2-methyl-1 H -indol-5-yloxy)-5-methylpyrrolo[2,1- f ][1,2,4]triazin-6-yloxy)propan-2-ol) is reported for the first time. Crystallographic parameters for brivanib: M = 370 g/mol, monoclinic space group P 2 1 , a = 10.3268(5) Å, b = 7.9377(4) Å, c =...
Gespeichert in:
| Veröffentlicht in: | Crystallography reports 2022-12, Vol.67 (7), p.1183-1186 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1186 |
|---|---|
| container_issue | 7 |
| container_start_page | 1183 |
| container_title | Crystallography reports |
| container_volume | 67 |
| creator | Cai, Jie Zhang, Ruirui |
| description | Crystal structure of brivanib ((
R
)-1-(4-(4-fluoro-2-methyl-1
H
-indol-5-yloxy)-5-methylpyrrolo[2,1-
f
][1,2,4]triazin-6-yloxy)propan-2-ol) is reported for the first time. Crystallographic parameters for brivanib:
M
= 370 g/mol, monoclinic space group
P
2
1
,
a
= 10.3268(5) Å,
b
= 7.9377(4) Å,
c
= 11.0046(5) Å, β = 98.011(2)°,
Z
= 2. The molecules are linked into a two-dimensional layered structure by intermolecular interactions N–H⋅⋅⋅O and O–H⋅⋅⋅N. |
| doi_str_mv | 10.1134/S1063774522070045 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2775252374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2775252374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c198t-e7271ffe91d129cf2dce77f5ba0d1e6ff68fc827c801eae58f5f2b7ed7f1fce3</originalsourceid><addsrcrecordid>eNp1kc1KxDAQx4so-PkA3gpeFDaaSZum603FdQVFcPcgiJRsmrhdsk2dtmJ9Ih_TLF30IMLADPz-H4cJgkOgpwBRfDYBmkRCxJwxKiiN-UawAzxhJEmHT5v-9pis-HawW9cLSmmaQrwTfN07q1VrJYaTBlvVtKhDWebhpK1QLn_gBap50eieOxNeYvEuy2J2Hh4_nhAgx_FqRrZ16AgjS93MO0tgTIoyd5Zw0ln30Z34o0dVh-ise2YDIOYlfIYBG8QvDRbysyhJspZX6CpZ-jxn94MtI22tD9Z7L5iOrqdXY3L3cHN7dXFHFAzThmjBBBijh5ADGyrDcqWFMHwmaQ46MSZJjUqZUCkFLTVPDTdsJnQuDBilo73gqI_11W-trpts4VosfWPGhOCMs0jEXgW9SqGra9Qmq7BYSuwyoNnqH9mff3gP6z2115avGn-T_zd9AxowjP8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2775252374</pqid></control><display><type>article</type><title>Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol</title><source>SpringerLink Journals - AutoHoldings</source><creator>Cai, Jie ; Zhang, Ruirui</creator><creatorcontrib>Cai, Jie ; Zhang, Ruirui</creatorcontrib><description>Crystal structure of brivanib ((
R
)-1-(4-(4-fluoro-2-methyl-1
H
-indol-5-yloxy)-5-methylpyrrolo[2,1-
f
][1,2,4]triazin-6-yloxy)propan-2-ol) is reported for the first time. Crystallographic parameters for brivanib:
M
= 370 g/mol, monoclinic space group
P
2
1
,
a
= 10.3268(5) Å,
b
= 7.9377(4) Å,
c
= 11.0046(5) Å, β = 98.011(2)°,
Z
= 2. The molecules are linked into a two-dimensional layered structure by intermolecular interactions N–H⋅⋅⋅O and O–H⋅⋅⋅N.</description><identifier>ISSN: 1063-7745</identifier><identifier>EISSN: 1562-689X</identifier><identifier>DOI: 10.1134/S1063774522070045</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Crystal structure ; Crystallography ; Crystallography and Scattering Methods ; Molecular structure ; Physics ; Physics and Astronomy ; Structure of Organic Compounds</subject><ispartof>Crystallography reports, 2022-12, Vol.67 (7), p.1183-1186</ispartof><rights>Pleiades Publishing, Inc. 2022. ISSN 1063-7745, Crystallography Reports, 2022, Vol. 67, No. 7, pp. 1183–1186. © Pleiades Publishing, Inc., 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c198t-e7271ffe91d129cf2dce77f5ba0d1e6ff68fc827c801eae58f5f2b7ed7f1fce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S1063774522070045$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S1063774522070045$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Cai, Jie</creatorcontrib><creatorcontrib>Zhang, Ruirui</creatorcontrib><title>Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol</title><title>Crystallography reports</title><addtitle>Crystallogr. Rep</addtitle><description>Crystal structure of brivanib ((
R
)-1-(4-(4-fluoro-2-methyl-1
H
-indol-5-yloxy)-5-methylpyrrolo[2,1-
f
][1,2,4]triazin-6-yloxy)propan-2-ol) is reported for the first time. Crystallographic parameters for brivanib:
M
= 370 g/mol, monoclinic space group
P
2
1
,
a
= 10.3268(5) Å,
b
= 7.9377(4) Å,
c
= 11.0046(5) Å, β = 98.011(2)°,
Z
= 2. The molecules are linked into a two-dimensional layered structure by intermolecular interactions N–H⋅⋅⋅O and O–H⋅⋅⋅N.</description><subject>Crystal structure</subject><subject>Crystallography</subject><subject>Crystallography and Scattering Methods</subject><subject>Molecular structure</subject><subject>Physics</subject><subject>Physics and Astronomy</subject><subject>Structure of Organic Compounds</subject><issn>1063-7745</issn><issn>1562-689X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kc1KxDAQx4so-PkA3gpeFDaaSZum603FdQVFcPcgiJRsmrhdsk2dtmJ9Ih_TLF30IMLADPz-H4cJgkOgpwBRfDYBmkRCxJwxKiiN-UawAzxhJEmHT5v-9pis-HawW9cLSmmaQrwTfN07q1VrJYaTBlvVtKhDWebhpK1QLn_gBap50eieOxNeYvEuy2J2Hh4_nhAgx_FqRrZ16AgjS93MO0tgTIoyd5Zw0ln30Z34o0dVh-ise2YDIOYlfIYBG8QvDRbysyhJspZX6CpZ-jxn94MtI22tD9Z7L5iOrqdXY3L3cHN7dXFHFAzThmjBBBijh5ADGyrDcqWFMHwmaQ46MSZJjUqZUCkFLTVPDTdsJnQuDBilo73gqI_11W-trpts4VosfWPGhOCMs0jEXgW9SqGra9Qmq7BYSuwyoNnqH9mff3gP6z2115avGn-T_zd9AxowjP8</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Cai, Jie</creator><creator>Zhang, Ruirui</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221201</creationdate><title>Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol</title><author>Cai, Jie ; Zhang, Ruirui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c198t-e7271ffe91d129cf2dce77f5ba0d1e6ff68fc827c801eae58f5f2b7ed7f1fce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Crystal structure</topic><topic>Crystallography</topic><topic>Crystallography and Scattering Methods</topic><topic>Molecular structure</topic><topic>Physics</topic><topic>Physics and Astronomy</topic><topic>Structure of Organic Compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Jie</creatorcontrib><creatorcontrib>Zhang, Ruirui</creatorcontrib><collection>CrossRef</collection><jtitle>Crystallography reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Jie</au><au>Zhang, Ruirui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol</atitle><jtitle>Crystallography reports</jtitle><stitle>Crystallogr. Rep</stitle><date>2022-12-01</date><risdate>2022</risdate><volume>67</volume><issue>7</issue><spage>1183</spage><epage>1186</epage><pages>1183-1186</pages><issn>1063-7745</issn><eissn>1562-689X</eissn><abstract>Crystal structure of brivanib ((
R
)-1-(4-(4-fluoro-2-methyl-1
H
-indol-5-yloxy)-5-methylpyrrolo[2,1-
f
][1,2,4]triazin-6-yloxy)propan-2-ol) is reported for the first time. Crystallographic parameters for brivanib:
M
= 370 g/mol, monoclinic space group
P
2
1
,
a
= 10.3268(5) Å,
b
= 7.9377(4) Å,
c
= 11.0046(5) Å, β = 98.011(2)°,
Z
= 2. The molecules are linked into a two-dimensional layered structure by intermolecular interactions N–H⋅⋅⋅O and O–H⋅⋅⋅N.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S1063774522070045</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1063-7745 |
| ispartof | Crystallography reports, 2022-12, Vol.67 (7), p.1183-1186 |
| issn | 1063-7745 1562-689X |
| language | eng |
| recordid | cdi_proquest_journals_2775252374 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Crystal structure Crystallography Crystallography and Scattering Methods Molecular structure Physics Physics and Astronomy Structure of Organic Compounds |
| title | Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A08%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Structure%20and%20Supramolecular%20Architecture%20of%20Brivanib:%20(R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo%5B2,1-f%5D%20%5B1,2,4%5Dtriazin-6-yloxy)propan-2-ol&rft.jtitle=Crystallography%20reports&rft.au=Cai,%20Jie&rft.date=2022-12-01&rft.volume=67&rft.issue=7&rft.spage=1183&rft.epage=1186&rft.pages=1183-1186&rft.issn=1063-7745&rft.eissn=1562-689X&rft_id=info:doi/10.1134/S1063774522070045&rft_dat=%3Cproquest_cross%3E2775252374%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2775252374&rft_id=info:pmid/&rfr_iscdi=true |